INS and type 2 diabetes mellitus: Hypoglycemia-associated autonomic failure (HAAF), which is characterized by defective glucose counterregulation during hypoglycemia, is a well-known neuroendocrine complication in children and adults on insulin therapy for type 1 and type 2 diabetes [2,3].